Clinical Trials Browser

Phase 3 × OTHER × Vaccines × Clear all

NCT06866574 2025-07-31

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

Phase 3 Active not recruiting

Gastrointestinal

Anus Neoplasms, Condylomata Acuminata

NCT00501137 2015-04-10

BCGov-01

Phase 3 Completed

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT01512784 2012-01-19

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

Phase 3 Unknown

HIV Infections, Papillomavirus Infections